Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 9
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Times cited: 37
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome.
Times cited: 69